Loading organizations...
§ Venture Capital · 241 East Michigan Avenue, Kalamazoo, MI 49007
SWMF Life Science Fund operates as a venture capital fund that provides direct equity investment to entrepreneurs developing early-stage life science companies. The fund extends beyond capital, offering substantial support services to its portfolio companies, encompassing crucial industry expertise, strategic regulatory guidance, and assistance navigating complex reimbursement landscapes.
The fund was formally organized in 2004, originating in Kalamazoo, Michigan, as an initiative by Southwest Michigan First, an economic development organization. The core insight behind its creation was to address a need for specialized capital and support for nascent life science ventures, particularly within the region. It is co-managed through a collaborative partnership with Open Prairie Ventures.
SWMF Life Science Fund targets early-stage life science companies, with a primary geographic focus on the seven-county area of Southwest Michigan. Its long-term vision centers on serving as an economic catalyst, aiming to stimulate job creation and foster innovation by strategically investing in and nurturing the growth of groundbreaking enterprises within the vital life science sector.
SWMF Life Science Fund has 3 tracked investments across 2 companies. The latest tracked deal is $13.3M Debt / Other Equity in Monteris Medical in October 2013.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 22, 2013 | Monteris Medical | $13.3M Debt / Other Equity | Gary Bantle | Christopher Herr |
| Jan 7, 2013 | Monteris Medical | $7.8M Other Equity | Gary Bantle | Richardson GMP |
| Oct 17, 2012 | Tolera Therapeutics | $5.5M Series B | Robert Hackenberg | Triathlon Medical Ventures |